ReviewJapanese journal of radiology2025
The clinical utility of ventilation-perfusion scintigraphy in the classification of pulmonary hypertension.
Review in Japanese journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Pulmonary hypertension encompasses a diverse set of conditions characterized by increased pressure in the pulmonary arteries. Proper classification is crucial for effective diagnosis and treatment. Ventilation-perfusion scintigraphy plays a vital role in imaging, especially in differentiating chronic thromboembolic pulmonary hypertension from other types of pulmonary hypertension. This article reviews the clinical applications of ventilation-perfusion scintigraphy in the classification of pulmonary hypertension, with particular focus on its relevance to groups 1 (pulmonary arterial hypertension), 3 (pulmonary hypertension associated with lung diseases or hypoxia), and 4 (chronic thromboembolic pulmonary hypertension). In addition, it explores recent technological advances and their impact on clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.